CE mark approval follows the US FDA approval from December 2022. Treatment can enable qualifying patients to have their second side treated at least nine months after first side. Essential tremor is ...
The MarketWatch News Department was not involved in the creation of this content. Reimbursement now enables hospitals across France to offer incisionless brain therapy for medication--refractory ...
MIAMI, July 13, 2020 /PRNewswire/ -- INSIGHTEC, a global medical technology innovator of incisionless surgery, announced today achievement of complete Medicare coverage across all 50 states for ...
HAIFA, Israel and MIAMI, Fla. , Sept. 22, 2023 /PRNewswire/ -- Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that Humana is the ...
MIAMI, Sept. 16, 2025 /PRNewswire/ -- Insightec, a global healthcare innovator pioneering the use of focused ultrasound to transform patient care, today announced that Lord Julian Fellowes, ...
Insightec Ltd. broadened its CE mark approval for the Exablate Neuro, a focused ultrasound platform which treats essential tremors, to allow patients to have their second side treated. With some 60 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results